Huan Zhang

发表

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

C. Zhan, Qun Wang, L. Tan, 2022, Molecular therapy. Nucleic acids.

Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma

Songtao Xu, C. Zhan, Lin Wang, 2021, Thoracic cancer.

Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma

C. Zhan, Qun Wang, Zhencong Chen, 2022, Technology in cancer research & treatment.

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma

C. Zhan, Qun Wang, Hao Wang, 2022, Translational oncology.

Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity

C. Zhan, Qun Wang, Jianrong Zhang, 2022, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Identification and validation of the mitochondrial function related hub genes by unsupervised machine learning and multi-omics analyses in lung adenocarcinoma

C. Zhan, Miao Lin, Zhencong Chen, 2022, Heliyon.

Genomic And Tumor Microenvironment Differences Between Cell Cycle Progression Pathway Altered/Non-Altered Patients With Lung Adenocarcinoma

Dejun Zeng, C. Zhan, Guoshu Bi, 2022, Frontiers in Oncology.

Genetic and tumor microenvironment differences between cell cycle progression pathway altered/non-altered patients with lung adenocarcinoma

Dejun Zeng, C. Zhan, Guoshu Bi, 2021 .

Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma

C. Zhan, Qun Wang, Guoshu Bi, 2022, Cancer medicine.

Nontumor cells in Tumor Specimens Impair the Accuracy of Quantitative Polymerase Chain Reaction in the Detection of Programmed Death-Ligand 1 Copy Number Variant and mRNA Expression.

C. Zhan, Zhencong Chen, Qihai Sui, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Ground glass nodules with scattered or eccentric island‐shaped consolidations may have poor outcomes

C. Zhan, Qun Wang, L. Tan, 2023, Cancer Innovation.

Hepatic nuclear factor 4 alpha promotes the ferroptosis of lung adenocarcinoma via transcriptional activation of cytochrome P450 oxidoreductase

C. Zhan, Zongwu Lin, Guoshu Bi, 2023, PeerJ.

Multi-Omics Analysis of Cancer Cell Lines with High/Low Ferroptosis Scores and Development of a Ferroptosis-Related Model for Multiple Cancer Types

Dejun Zeng, C. Zhan, Guoshu Bi, 2021, Frontiers in Cell and Developmental Biology.

HMGA2 regulates circular RNA ASPH to promote tumor growth in lung adenocarcinoma

W. Liao, G. Jiang, Lie Yang, 2020, Cell Death & Disease.

The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data

C. Zhan, Zongwu Lin, Qun Wang, 2023, Cell & Bioscience.

AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic target.

C. Zhan, Qun Wang, Guoshu Bi, 2023, Pharmacological research.

HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway

C. Zhan, Lin Wang, Guoshu Bi, 2023, PeerJ.

Inhibition of PKA/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer

C. Zhan, Guoshu Bi, Zhengyang Hu, 2023, Respiratory Research.

Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer

C. Zhan, Guoshu Bi, Zhencong Chen, 2024, Nature communications.